From molecular mimicry to cross-reactivity or pathogen expansion? A hypothesis
- PMID: 16807670
- DOI: 10.1007/s10067-006-0352-9
From molecular mimicry to cross-reactivity or pathogen expansion? A hypothesis
Abstract
Very recently, several studies have convincingly demonstrated the role of infection in the development of the antiphospholipid syndrome. Cross antibody-mediated reactivity due to molecular mimicry between endothelial glycoproteins and microbial products was considered as an important pathogenic mechanism. However, another consequence of the molecular mimicry may be proposed. Similar tissues have less likelihood of being rejected and have a greater chance of being accepted by the host. According to this principle, pathogens with common-to-host antigens may attach readily and not be eliminated. A direct expansion of such pathogens may involve new territories. The targets of the approach 1, "from molecular mimicry to cross-reactivity," are T-B cells system inhibition-modulation. The targets of approach 2, "from molecular mimicry to pathogen expansion," are pathogens, enforcement of barriers, elimination techniques, and preventive strategy.
Similar articles
-
The Guillain-Barré syndrome: a true case of molecular mimicry.Trends Immunol. 2004 Feb;25(2):61-6. doi: 10.1016/j.it.2003.12.004. Trends Immunol. 2004. PMID: 15102364 Review.
-
Infections and vaccines in the etiology of antiphospholipid syndrome.Curr Opin Rheumatol. 2012 Jul;24(4):389-93. doi: 10.1097/BOR.0b013e32835448b8. Curr Opin Rheumatol. 2012. PMID: 22617823 Review.
-
Graph-theoretical comparison of protein surfaces reveals potential determinants of cross-reactivity and the molecular mimicry.Mol Immunol. 2010 Jan;47(4):719-25. doi: 10.1016/j.molimm.2009.10.020. Epub 2009 Nov 25. Mol Immunol. 2010. PMID: 19939450
-
Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations.Clin Immunol. 2004 Aug;112(2):190-9. doi: 10.1016/j.clim.2004.02.018. Clin Immunol. 2004. PMID: 15240163 Review.
-
Molecular mimicry: lessons from an experimental model of antiphospholipid syndrome in naive mice.Isr Med Assoc J. 2000 Dec;2 Suppl:20-1. Isr Med Assoc J. 2000. PMID: 11344860 No abstract available.
Cited by
-
The SAPHO syndrome revisited with an emphasis on spinal manifestations.Skeletal Radiol. 2015 Jan;44(1):9-24. doi: 10.1007/s00256-014-2025-0. Epub 2014 Oct 21. Skeletal Radiol. 2015. PMID: 25331355 Review.
-
SAPHO syndrome: is a range of pathogen-associated rheumatic diseases extended?Arthritis Res Ther. 2009;11(6):131. doi: 10.1186/ar2837. Epub 2009 Nov 5. Arthritis Res Ther. 2009. PMID: 19895718 Free PMC article.
-
Sialic Acid-Siglec Axis as Molecular Checkpoints Targeting of Immune System: Smart Players in Pathology and Conventional Therapy.Int J Mol Sci. 2020 Jun 19;21(12):4361. doi: 10.3390/ijms21124361. Int J Mol Sci. 2020. PMID: 32575400 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical